Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:
“If exercise were a drug, we would call it multi-target vascular therapy.
Exercise is often framed as ‘cardiovascular risk reduction.’ But that description undersells what it actually does.
Exercise is not simply a statistical modifier of event probability.
It is a biological modifier of vascular trajectory.
Regular physical activity has been shown to:
- Improve endothelial nitric oxide bioavailability
- Reduce systemic inflammatory tone
- Enhance insulin sensitivity independent of weight loss
- Improve autonomic balance and blood pressure variability
- Influence plaque phenotype toward more stable morphology
Most pharmacologic therapies act on a single pathway.
Exercise simultaneously influences lipid metabolism, inflammation, metabolic pressure and vascular function.
If cardiovascular risk is a curve, exercise does not just shift it downward. It reduces its slope.
That distinction matters as we rethink prevention in an era of genomics, AI and precision risk modeling.
I explore this in my latest CardioForesight essay:
‘Exercise Doesn’t Just Lower Risk, It Changes Vascular Biology.'”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke